Data Dictionary: Belgian Cancer Registry: Difference between revisions
From Beacon
No edit summary |
m (Update categories.) |
||
| (10 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forresearchers</span> <span style="display:none">belgiumcountry</span> | |||
Go back to [[Belgium]] page | Go back to [[Belgium]] page | ||
Sources - Cancer Diagnosis Variables: [https://kankerregister.org/nl/kankerdiagnoses Click here to learn more]; Screening Variables: [https://kankerregister.org/nl/screening Click here to learn more]. | |||
'''Table 1:''' Cancer Diagnosis Variables. | |||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| Unique patient identification including demographic parameters (i.e., date of birth, zip code) | |||
|- | |||
| Unique identification of the care program and hospital | |||
|- | |||
| Diagnosis according to international classification | |||
|- | |- | ||
| | | Date of incidence | ||
|- | |- | ||
| | | Tumour stage (cTNM) | ||
|- | |- | ||
| | | Conclusion of the pathological report (including pTNM) | ||
|- | |- | ||
| | | Treatment with reference to guidelines or justification of deviation | ||
|- | |- | ||
| | | Follow-up plan | ||
|- | |- | ||
| | | Side effects | ||
|- | |- | ||
| | | Disease-free survival and survival (i.e., treatment outcome) | ||
|- | |- | ||
| | | Date of death | ||
|- | |- | ||
| | | Gender | ||
|- | |||
| Region | |||
|- | |||
| Incidence year | |||
|- | |||
| 5-year age group (only for absolute numbers and gross incidence) | |||
|} | |} | ||
'''Table 2:''' Screening Variables. | |||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| Aspects of Participation and Screening Test Usage | | Aspects of Participation and Screening Test Usage | ||
Latest revision as of 13:25, 2 December 2025
Go back to Belgium page
Sources - Cancer Diagnosis Variables: Click here to learn more; Screening Variables: Click here to learn more.
Table 1: Cancer Diagnosis Variables.
| Unique patient identification including demographic parameters (i.e., date of birth, zip code) |
| Unique identification of the care program and hospital |
| Diagnosis according to international classification |
| Date of incidence |
| Tumour stage (cTNM) |
| Conclusion of the pathological report (including pTNM) |
| Treatment with reference to guidelines or justification of deviation |
| Follow-up plan |
| Side effects |
| Disease-free survival and survival (i.e., treatment outcome) |
| Date of death |
| Gender |
| Region |
| Incidence year |
| 5-year age group (only for absolute numbers and gross incidence) |
Table 2: Screening Variables.
| Aspects of Participation and Screening Test Usage |
| Aspects of participation |
| Use of the screening test in the target group |
| Results obtained and their use (including cancer detection rate, sensitivity, and specificity) |
| Cyto-histopathology register |
| Results of further follow-up |
